Publication | Open Access
A phase II study of enzastaurin, a protein kinase C beta inhibitor, in patients with relapsed or refractory mantle cell lymphoma
97
Citations
29
References
2007
Year
Hematological MalignancyLymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyPhase Ii StudyPathologyCancer TreatmentOncology
| Year | Citations | |
|---|---|---|
Page 1
Page 1